Wilms Tumor in Horseshoe Kidney

Authors

  • Allan Keithel Molina Estrada Residente V en la Maestría en Cirugía General del Hospital Roosevelt Guatemala y Universidad de San Carlos de Guatemala
  • Fernando González Hospital Roosevelt de Guatemala, Universidad de San Carlos de Guatemala, Hospital Sant Joan de Deu, Barcelona, España
  • Erwin Hernández Hospital General San Juan de Dios, Universidad de San Carlos de Guatemala, University Hospital, Mobile Alabama, Estados Unidos de América
  • Javier Bolaños Hospital Roosevelt de Guatemala, Universidad de San Carlos de Guatemala, Boston Children´s Hospital, Massachusetts, Estados Unidos de América

DOI:

https://doi.org/10.54212/27068048.v9i1.20

Keywords:

horseshoe kidney, nephroblastoma, Wilms tumor, radical nephrectomy

Abstract

Introduction: The horseshoe kidney is the most common fusion anomaly. Appears in 1 out of every 400 births, Wilms tumor or Nephroblastoma is the second most frequent abdominal tumor in pediatric age and accounts for more than 90% of kidney tumors in pediatrics. TW is the first example of cancer in which significant cure rates were achieved thanks to multimodal therapies including chemotherapy, radical nephrectomy, and radiation therapy. Objective: To present the clinical case of a patient with a diagnosis of Horseshoe Kidney with unusual presentation of a Wilms Tumor through radical nephrectomy and postoperative chemotherapy using the NTWS 5 protocol. Methods: The report of a 10-year-old male patient with Wilms Tumor in a Kidney in Horseshoe, with review and comparison of the protocols NTWS 5 and S.I.O.P. Result: Radical nephrectomy was performed with neoplasia-free surgical margins without finding metastases to neighboring organs. Adjuvant chemotherapy is given for 24 weeks with complete remission of the disease and adequate kidney function. Conclusions: The objectives of the treatment are to achieve a complete cure with a low drug toxicity and to preserve an adequate renal function. Surgery continues to be the mainstay of treatment, the discussion is focused on the use of neoadjuvant or adjuvant therapy and what the recommended medications and doses should be. All TW patients should receive Adjuvant Chemotherapy. The use of radiotherapy is essential in most cases.

Downloads

Download data is not yet available.

References

Andréu García A., Molina Burgos R., Coronel Sánchez B., Navío Perales J., Botella Almodóvar R., Llamazares Cachá G. Carcinoma renal de istmo en riñón en herradura: A propósito de un caso. Actas Urol Esp [Internet]. 2008 Feb [citado 2020 Oct 05]; 32(2): 249-252. https://doi.org/10.1016/S0210-4806(08)73821-X DOI: https://doi.org/10.1016/S0210-4806(08)73821-X

Salas I, Cortés Y, Zurivi A, Barroso A, Osorio M, Orozco J, Ramírez H. Riñón en herradura y carcinoma de células claras. A propósito de un caso. Ana Rad Mex. MEX [Internet] 2008 Mar [Citado 2020 oct 04]; 3(1) 199-204. Disponible en: https://www.medigraphic.com/pdfs/anaradmex/arm-2008/arm083i.pdf

Herrera-Toro NH, Peña-Aguirre L, Arango-Rave ME. Tumor de Wilms: experiencia de 12 años en dos hospitales de alto nivel en Medellín, Colombia. Iatreia. 2019 Abr-Jun; 32(2):82-91. https://doi.org/10.17533/udea.iatreia.13 DOI: https://doi.org/10.17533/udea.iatreia.13

Illade L, Hernández C, Cormenzana M, Lassaletta A, Andion M, Ruano D, Fioravantti V, Madero L. Tumor de Wilms: revisión de nuestra experiencia en los últimos 15 años. Wilms tumour: A review of 15 years recent experience. An Ped. Barcelona. 2018; 88 (3): 140-149. Disponible en: https://reader.elsevier.com/reader/sd/pii/S1695403317301649?token=C2B3C3C86B54AA767DA119F59FE42D488CF25D9C2B706591D1CF64563B44C06FEB8B505425982610B082C394B1D837D6.

Published

2021-06-30

How to Cite

Molina Estrada, A. K. ., González, F. ., Hernández , E., & Bolaños , J. (2021). Wilms Tumor in Horseshoe Kidney. Revista Guatemalteca De Urología, 9(1), 41–48. https://doi.org/10.54212/27068048.v9i1.20

Issue

Section

Case Reports Articles